DOI QR코드

DOI QR Code

Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy

  • Kim, Jung Ok (Department of Pediatrics, Jeju National University Hospital) ;
  • Kim, Yeo Hyang (Department of Pediatrics, Kyungpook National University School of Medicine) ;
  • Hyun, Myung Chul (Department of Pediatrics, Kyungpook National University School of Medicine)
  • Received : 2015.05.28
  • Accepted : 2015.10.02
  • Published : 2016.02.15

Abstract

Purpose: We evaluated the characteristics of patients with Kawasaki disease (KD) who presented with only fever and cervical lymphadenopathy on admission, and compared them with the characteristics of those who presented with typical features but no cervical lymphadenopathy. Methods: We enrolled 98 patients diagnosed with KD. Thirteen patients had only fever and cervical lymphadenopathy on the day of admission (group 1), 31 had typical features with cervical lymphadenopathy (group 2), and 54 had typical features without cervical lymphadenopathy (group 3). Results: The mean age ($4.3{\pm}2.1$ years) and duration of fever ($7.5{\pm}3.6$ days) before the first intravenous immunoglobulin (IVIG) administration were highest in group 1 (P=0.001). Moreover, this group showed higher white blood cell and neutrophil counts, and lower lymphocyte counts after the first IVIG administration as compared to the other groups (P =0.001, P =0.001, and P =0.003, respectively). Group 1 also had a longer duration of hospitalization and higher frequency of second-line treatment as compared to groups 2 and 3 (group 1 vs. group 2, P =0.000 and P =0.024; group 1 vs. group 3, P =0.000 and P =0.007). A coronary artery z score of >2.5 was frequently observed in group 1 than in group 3 (P = 0.008). Conclusion: KD should be suspected in children who are unresponsive to antibiotics and have prolonged fever and cervical lymphadenopathy, which indicates that KD is associated with the likelihood of requiring second-line treatment and risk of developing coronary artery dilatation.

Keywords

References

  1. Kim DS. Kawasaki disease. Yonsei Med J 2006;47:759-72. https://doi.org/10.3349/ymj.2006.47.6.759
  2. Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 2014;33:24-7. https://doi.org/10.1097/INF.0000000000000010
  3. Ghelani SJ, Sable C, Wiedermann BL, Spurney CF. Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol 2012;33:1097-103. https://doi.org/10.1007/s00246-012-0232-9
  4. Tashiro N, Matsubara T, Uchida M, Katayama K, Ichiyama T, Furukawa S. Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease. Pediatrics 2002;109:E77-7. https://doi.org/10.1542/peds.109.5.e77
  5. Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meissner C, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr 1991;118:680-6. https://doi.org/10.1016/S0022-3476(05)80026-5
  6. Sung RY, Ng YM, Choi KC, Mok GC, Cheng YW, Ho MH, et al. Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease. Pediatr Infect Dis J 2006;25:521-5. https://doi.org/10.1097/01.inf.0000215263.96289.1c
  7. Yanagi S, Nomura Y, Masuda K, Koriyama C, Sameshima K, Eguchi T, et al. Early diagnosis of Kawasaki disease in patients with cervical lymphadenopathy. Pediatr Int 2008;50:179-83. https://doi.org/10.1111/j.1442-200X.2008.02547.x
  8. Kubota M, Usami I, Yamakawa M, Tomita Y, Haruta T. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations. J Paediatr Child Health 2008;44:359-62. https://doi.org/10.1111/j.1440-1754.2008.01310.x
  9. Nomura Y, Arata M, Koriyama C, Masuda K, Morita Y, Hazeki D, et al. A severe form of Kawasaki disease presenting with only fever and cervical lymphadenopathy at admission. J Pediatr 2010;156:786-91. https://doi.org/10.1016/j.jpeds.2009.11.042
  10. Kanegaye JT, Van Cott E, Tremoulet AH, Salgado A, Shimizu C, Kruk P, et al. Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease. J Pediatr 2013;162:1259-63, 1263.e1-2. https://doi.org/10.1016/j.jpeds.2012.11.064
  11. Roh K, Lee SW, Yoo J. CT analysis of retropharyngeal abnormality in Kawasaki disease. Korean J Radiol 2011;12:700-7. https://doi.org/10.3348/kjr.2011.12.6.700
  12. Baek HJ, Lee JH, Lim HK, Lee HY, Baek JH. Diagnostic accuracy of the clinical and CT findings for differentiating Kikuchi's disease and tuberculous lymphadenitis presenting with cervical lymphadenopathy. Jpn J Radiol 2014;32:637-43. https://doi.org/10.1007/s11604-014-0357-2
  13. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33. https://doi.org/10.1542/peds.2004-2182
  14. Burns JC. Kawasaki disease update. Indian J Pediatr 2009;76:71-6. https://doi.org/10.1007/s12098-009-0031-3
  15. Dallaire F, Dahdah N. New equations and a critical appraisal of coronary artery Z scores in healthy children. J Am Soc Echocardiogr 2011;24:60-74. https://doi.org/10.1016/j.echo.2010.10.004
  16. Meier JD, Grimmer JF. Evaluation and management of neck masses in children. Am Fam Physician 2014;89:353-8.
  17. Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD. Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 2005;24:998-1004. https://doi.org/10.1097/01.inf.0000183786.70519.fa
  18. Meissner HC, Leung DY. Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr Infect Dis J 2000;19:91-4. https://doi.org/10.1097/00006454-200002000-00001
  19. Leahy TR, Cohen E, Allen UD. Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: a case report. Can J Infect Dis Med Microbiol 2012;23:137-9.
  20. Choi SH, Kim HJ. A case of Kawasaki disease with coexistence of a parapharyngeal abscess requiring incision and drainage. Korean J Pediatr 2010;53:855-8. https://doi.org/10.3345/kjp.2010.53.9.855
  21. Fan PC, Chiu CH, Yen MH, Huang YC, Li CC, Lin TY. School-aged children with Kawasaki disease: high incidence of cervical lymphadenopathy and coronary artery involvement. J Paediatr Child Health 2003;39:55-7. https://doi.org/10.1046/j.1440-1754.2003.00085.x
  22. Lee KY, Hong JH, Han JW, Lee JS, Lee BC, Burgner D. Features of Kawasaki disease at the extremes of age. J Paediatr Child Health 2006;42:423-7. https://doi.org/10.1111/j.1440-1754.2006.00898.x
  23. Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2006;149:237-40. https://doi.org/10.1016/j.jpeds.2006.03.050
  24. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006;113:2606-12. https://doi.org/10.1161/CIRCULATIONAHA.105.592865

Cited by

  1. 발열과 림프절 종대를 보인 환자에서 화농성 경부 림프절염과 가와사키병의 감별 진단 vol.23, pp.3, 2016, https://doi.org/10.14776/piv.2016.23.3.188
  2. 경부 림프절염로 발현된 가와사키병과 급성 편측 경부 림프절염의 비교 vol.23, pp.3, 2016, https://doi.org/10.14776/piv.2016.23.3.217
  3. Recent advances in the diagnosis of Kawasaki disease vol.5, pp.1, 2016, https://doi.org/10.22470/pemj.2018.00220
  4. Diagnosis and management of Kawasaki disease vol.63, pp.7, 2016, https://doi.org/10.5124/jkma.2020.63.7.374
  5. A febrile child with a ‘bunch of grapes’ appearance on neck ultrasonography vol.51, pp.2, 2016, https://doi.org/10.1177/0049475520975943